CORONA REMEDIES
Back to Income Statement
|
CORONA REMEDIES Last 5 Year Profit Before Tax History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | |
|---|---|---|---|---|
| Profit Before Tax | ₹199 Cr | ₹1,185 Cr | ₹111 Cr | ₹111 Cr |
What is the latest Profit Before Tax of CORONA REMEDIES ?
| Year | Profit Before Tax |
|---|---|
| Mar2026 | ₹199 Cr |
| Mar2025 | ₹1,185 Cr |
| Mar2024 | ₹111 Cr |
| Mar2023 | ₹111 Cr |
How is Profit Before Tax of CORONA REMEDIES Trending?
| Years | Profit Before Tax | % Change | |
|---|---|---|---|
| Mar2026 | ₹199 Cr | -83.24 | |
| Mar2025 | ₹1,185 Cr | 968.48 | |
| Mar2024 | ₹111 Cr | 0.00 | |
| Mar2023 | ₹111 Cr | - | |
Compare Profit Before Tax of peers of CORONA REMEDIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| CORONA REMEDIES | ₹12,310.7 Cr | -0.7% | -6.8% | NA | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹418,684.0 Cr | 0.1% | -5% | 5.4% | Stock Analytics | |
| DIVIS LABORATORIES | ₹241,311.0 Cr | -1.7% | 0.2% | 39.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹173,079.0 Cr | -2.5% | -5.5% | 30.2% | Stock Analytics | |
| CIPLA | ₹107,528.0 Cr | 0.9% | -2.6% | -14.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,667.0 Cr | 0.1% | 7.6% | -3.5% | Stock Analytics | |
CORONA REMEDIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| CORONA REMEDIES | -0.7% |
-6.8% |
|
| SENSEX | 2.7% |
-0.7% |
-10.5% |
You may also like the below Video Courses